Casper Es

515 total citations
19 papers, 398 citations indexed

About

Casper Es is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Casper Es has authored 19 papers receiving a total of 398 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 4 papers in Molecular Biology and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Casper Es's work include Cancer Treatment and Pharmacology (5 papers), Cancer therapeutics and mechanisms (3 papers) and Lung Cancer Treatments and Mutations (3 papers). Casper Es is often cited by papers focused on Cancer Treatment and Pharmacology (5 papers), Cancer therapeutics and mechanisms (3 papers) and Lung Cancer Treatments and Mutations (3 papers). Casper Es collaborates with scholars based in United States. Casper Es's co-authors include Harold M. van Es, Lewis Jl, Gralla Rj, D. P. Kelsen, Young Cw, Carla P. Gomes, Meinolf Sellmann, Golbey Rb, Esteban Cvitkovic and Wittes Re and has published in prestigious journals such as Soil Science Society of America Journal, Geoderma and Agronomy Journal.

In The Last Decade

Casper Es

17 papers receiving 363 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Casper Es United States 10 133 84 72 62 61 19 398
Ling Ouyang China 15 112 0.8× 64 0.8× 74 1.0× 25 0.4× 294 4.8× 51 734
Yulin Liu China 15 218 1.6× 70 0.8× 127 1.8× 160 2.6× 184 3.0× 42 830
S Neagu Romania 11 140 1.1× 152 1.8× 39 0.5× 156 2.5× 39 0.6× 31 529
Haichao Xu China 12 51 0.4× 74 0.9× 22 0.3× 21 0.3× 58 1.0× 24 344
Zhiwei Zhao China 16 121 0.9× 91 1.1× 43 0.6× 44 0.7× 339 5.6× 43 746
Tao Yue China 10 76 0.6× 152 1.8× 49 0.7× 47 0.8× 184 3.0× 28 641
Xianxin Li China 16 68 0.5× 90 1.1× 98 1.4× 29 0.5× 516 8.5× 53 862
George W. Cole United States 13 158 1.2× 29 0.3× 74 1.0× 20 0.3× 182 3.0× 36 471
M. Kennedy United Kingdom 15 183 1.4× 38 0.5× 31 0.4× 12 0.2× 49 0.8× 31 531
Xiaoting Ling China 10 69 0.5× 165 2.0× 12 0.2× 17 0.3× 57 0.9× 26 515

Countries citing papers authored by Casper Es

Since Specialization
Citations

This map shows the geographic impact of Casper Es's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Casper Es with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Casper Es more than expected).

Fields of papers citing papers by Casper Es

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Casper Es. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Casper Es. The network helps show where Casper Es may publish in the future.

Co-authorship network of co-authors of Casper Es

This figure shows the co-authorship network connecting the top 25 collaborators of Casper Es. A scholar is included among the top collaborators of Casper Es based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Casper Es. Casper Es is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Es, Harold M. van, Carla P. Gomes, Meinolf Sellmann, & Casper Es. (2007). Spatially-Balanced Complete Block designs for field experiments. Geoderma. 140(4). 346–352. 54 indexed citations
2.
Es, Harold M. van & Casper Es. (1993). Spatial Nature of Randomization and Its Effect on the Outcome of Field Experiments. Agronomy Journal. 85(2). 420–428. 68 indexed citations
3.
Es, Harold M. van, Casper Es, & D. K. Cassel. (1989). Application of Regionalized Variable Theory to Large‐Plot Field Experiments. Soil Science Society of America Journal. 53(4). 1178–1183. 12 indexed citations
4.
Es, Casper. (1989). Innovations: medical record standards compliance as a function of selected staff variables.. PubMed. 9(4). 79–89. 1 indexed citations
5.
Kelsen, D. P., et al.. (1985). Adenocarcinoma of unknown primary origin: treatment with vindesine and doxorubicin.. PubMed. 69(6). 591–4. 16 indexed citations
6.
Es, Casper, et al.. (1985). Phase II trial of 4-demethoxydaunorubicin in patients with advanced malignant melanoma.. PubMed. 69(7-8). 915–6. 8 indexed citations
7.
Es, Casper, et al.. (1984). Phase I evaluation of a biochemically designed combination: PALA, thymidine, and 5-FU.. PubMed. 68(3). 539–41. 3 indexed citations
8.
Berman, Ellin, Casper Es, Jane Howard, & Wittes Re. (1984). Phase II trial of 4'-epi-doxorubicin in patients with advanced malignant melanoma.. PubMed. 68(4). 679–80. 8 indexed citations
9.
Kris, Mark G., et al.. (1983). Phase II trial of 4'-epi-doxorubicin in patients with non-small cell lung cancer.. PubMed. 67(6). 591–2. 19 indexed citations
10.
Es, Casper, et al.. (1983). Phase II trial of PCNU in non-small cell lung cancer.. PubMed. 67(9). 837–837. 3 indexed citations
11.
Rj, Gralla, et al.. (1983). Phase I trial of PCNU.. PubMed. 67(11). 1027–9.
12.
Es, Casper, et al.. (1983). Ip cisplatin in patients with malignant ascites: pharmacokinetic evaluation and comparison with the iv route.. PubMed. 67(3). 235–8. 102 indexed citations
13.
Es, Casper, Gralla Rj, D. P. Kelsen, et al.. (1981). Phase II evaluation of N-(phosphonacetyl)-L-aspartic acid (PALA) in patients with non-small cell carcinoma of the lung.. PubMed. 64(4-5). 705–7. 12 indexed citations
14.
Rj, Gralla, et al.. (1981). Phase II evaluation of metoprine in patients with non-small-cell lung carcinoma.. PubMed. 4(3). 273–6. 2 indexed citations
15.
Es, Casper, et al.. (1980). Platinum concentrations in bile and plasma following rapid and 6-hour infusions of cis-dichlorodiammineplatinum(II).. PubMed. 63(11-12). 2023–5. 16 indexed citations
16.
Es, Casper, et al.. (1980). Phase I study of 6-diazo-5-oxo-L-norleucine (DON).. PubMed. 64(12). 1247–51. 22 indexed citations
17.
Es, Casper, Gralla Rj, D. P. Kelsen, Esteban Cvitkovic, & Golbey Rb. (1980). Phase II study of high-dose cis-dichlorodiammineplatinum(II) in the treatment of non-small cell lung cancer.. PubMed. 63(11-12). 2107–9. 39 indexed citations
18.
Rj, Gralla, et al.. (1980). Phase I trial of PALA.. PubMed. 64(12). 1301–5. 9 indexed citations
19.
Es, Casper & Gralla Rj. (1979). Phase II evaluation of chlorozotocin in patients with non-small cell carcinoma of the lung.. PubMed. 63(4). 549–50. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ling Ouyang Breakdown of academic impact, for papers by Yulin Liu Breakdown of academic impact, for papers by S Neagu Breakdown of academic impact, for papers by Haichao Xu Breakdown of academic impact, for papers by Zhiwei Zhao Breakdown of academic impact, for papers by Tao Yue Breakdown of academic impact, for papers by Xianxin Li Breakdown of academic impact, for papers by George W. Cole Breakdown of academic impact, for papers by M. Kennedy Breakdown of academic impact, for papers by Xiaoting Ling
Rankless by CCL
2026